ARIO PHARMA

Ario Pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhibitor, in two Phase 2 clinical trials that will read out in 2014. The company is managed by a highly experienced development team and supported by world-renowned KOLs in respiratory disease.

#People #Financial #Website #More

ARIO PHARMA

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2010-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.ariopharma.com

Total Employee:

Status:

Active

Contact:

(+44) 1223 493922

Total Funding:

3.1 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Organization Schema